Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

PurposeThe Cancer Genome Atlas Research Network identified Epstein-Barr-Virus (EBV)-positive gastric cancer as a distinct molecular subtype. The prevalence is 8-9% and the histological examination shows pronounced lymphocytic infiltration, elevated levels of IFN-γ and consequently overexpression of...

Full description

Bibliographic Details
Main Authors: Andrea Alberti, Gertraud Stocker, Florian Lordick, Ulrich T. Hacker, Benjamin Kobitzsch, Ivonne Haffner, Gian Luca Baiocchi, Manuel Zamparini, Guido A. M. Tiberio, Carla Baronchelli, Arnaldo Caruso, Paolo Bossi, Alfredo Berruti
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Oncology
Subjects:
gastric and gastroesophageal junction adenocarcinoma
epstein barr virus DNA
prognostic factor
disease-free survival
prospective multicenter study
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1276138/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1276138/full

Similar Items